As Congress Reconvenes, PBM Middlemen Remain on Defense as Questionable Practices, Bipartisan Transparency Legislation Drive Drug Pricing Discussion

As Congress reconvenes this week, the increasingly controversial role of Pharmacy Benefit Managers (PBMs) in the national drug pricing chain are again in the spotlight as bipartisan, bicameral bills to limit opaque PBM pricing practices drive the drug pricing discussion…Read More

National, Georgia LTC Pharmacy Leaders Praise U.S. Reps. Doug Collins, Buddy Carter Leadership in Taking on Unaccountable Pharmacy Benefit Manager (PBM) Drug Pricing Middlemen

As escalating drug prices have increasingly roiled consumers throughout Georgia, national and state Long Term Care (LTC) pharmacy leaders today praised the vigorous, persistent and effective efforts of U.S. Reps. Doug Collins (R-GA) and Buddy Carter (R-GA) in taking on the increasingly controversial Pharmacy Benefit Manager (PBM) middlemen…Read More

Wyden “C-Thru” Bill Helps Pull Back Curtain on Duplicitous PBM “Rebates,” Suspect Pricing Schemes, Related Anti-Competitive Behavior

Noting a torrent of bipartisan legislation recently introduced requiring Pharmacy Benefit Manager (PBM) drug middlemen to pull back the curtain on veiled, opaque pharmaceutical pricing practices, the Senior Care Pharmacy Coalition (SCPC) today backed Sen. Ron Wyden’s (D-OR) “Creating Transparency to Have Drug Rebates Unlocked Act” (C-THRU) bill…Read More

SCPC Looks Forward to Working with CMS Administrator Seema Verma to Hold PBMs Accountable for Opaque, Controversial Drug Pricing Practices

Following U.S. Senate confirmation of Seema Verma as the new Administrator of the Centers for Medicare and Medicaid Services (CMS), the Senior Care Pharmacy Coalition (SCPC) praised her approval and said the Long-Term Care (LTC) Pharmacy advocacy group looks forward to working with her to hold Pharmacy Benefit Managers (PBMs) more accountable for the opaque, controversial pricing practices that have spurred Congress to propose multiple legislative remedies to do so…Read More

SCPC Praises Collins/Loebsack Bill Boosting Generic Prescription Drug Payment Transparency

In praising U.S. Reps. Doug Collins (R-GA) and Dave Loebsack (D-IA) for introducing the Prescription Drug Price Transparency Act (H.R. 1316), Senior Care Pharmacy Coalition (SCPC) President and CEO Alan G. Rosenbloom observed that the nation’s drug pricing middlemen — Pharmacy Benefit Managers (PBMs) — are rightly facing a growing barrage of criticism from a widening group of bipartisan lawmakers demanding answers about rising prescription drug prices, and the practices driving increases……Read More

PBMs Swimming Against Rising Tide of More Drug Pricing Transparency

Morning Consult
Amid the public uproar surrounding skyrocketing drug prices, Pharmacy Benefit Managers — the pharmaceutical industry’s primary middlemen — are attracting new scrutiny from key members of Congress increasingly disturbed by benefit managers’ complex array of surreptitious pricing practices and protocols…..Read More

SCPC Praises Sen. Sherrod Brown for Raising Key LTC Pharmacy Concerns Regarding Controversial PBM Pricing Practices

Washington, DC — In conjunction with questions directed to Centers for Medicare & Medicaid Services (CMS) Administrator-nominee Seema Verma from members of the Senate Finance Committee, the Senior Care Pharmacy Coalition (SCPC) today praised Sen. Sherrod Brown (D-OH) for raising key issues of concern to the nation’s long term care (LTC) pharmacy sector…..Read More

SCPC Backs Bipartisan Senate, House Bills to Eliminate Retroactive PBM Middlemen Fees on Patients, LTC Pharmacies, Medicare Program

Washington, DC — The Senior Care Pharmacy Coalition (SCPC) today backed legislation introduced in the U.S. Senate and House of Representatives that will curtail the ability of drug industry middlemen — Pharmacy Benefit Managers (PBMs) — from extracting retroactive direct and indirect remuneration (DIR) fees in transactions with patients, long term care (LTC) pharmacies and the Medicare program….Read More

SCPC Praises Rep. Doug Collins’ Mission to Spotlight PBMs — “Drug Industry’s Middlemen”

Washington, DC — Commenting on new reporting in Axios noting that U.S. Rep. Doug Collins (R-GA) and others in Congress “are ready and willing” to shine a light on non-transparent Pharmacy Benefit Manager (PBM) pricing practices, the Senior Care Pharmacy Coalition (SCPC) today praised Collins’ intent to reintroduce and add items to his 2015 bill (H.R. 244 — Mac Transparency Act), which would require “greater transparency of the rebates, fees and costs” tied to PBMs….Read More

2017 Greets PBMs With New CMS Report Undermining “Rebate” Claims While Key GOP Senator Considers PBM Role in Higher Drug Prices

Washington, DC — The President and CEO of the Senior Care Pharmacy Coalition (SCPC) today predicted the increasingly apparent role of Pharmacy Benefit Managers (PBMs) as unaccountable middlemen in the national drug pricing chain will result in a higher level of scrutiny from Congress, regulators and the media in 2017….Read More

Twitter   LinkedIn